De Wit, R. De Bono, J. Sternberg, C.N. Fizazi, K. Tombal, B. Wülfing, C. Kramer, G. Eymard, J.-C. Bamias, A. Carles, J. Iacovelli, R. Melichar, B. Sverrisdóttir, Á. Theodore, C. Feyerabend, S. Helissey, C. Ozatilgan, A. Geffriaud-Ricouard, C. Castellano, D., Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer, The New England journal of medicine, (381), 2506-2518, 2019, Massachussetts Medical Society,